Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Urien

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Therapeutic Drug Monitoring|January 1, 1988
Comparison of different methods for lysing whole blood to measure cyclosporin A by radioimmunoassayC Hamberger, J Barre, S Urien, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
Location of probucol in lipoproteins inferred from compositional analysis of lipoprotein particles. An in-vitro studyJ M Bard, S Urien, J C Fruchart, et al.
Therapie|July 1, 1997
[Mediators involved in the nephrotoxicity of cyclosporin A]N Simon, J Barré, P Jolliet, et al.
Molecular Pharmacology|September 1, 1984
In vitro studies on the distribution of probucol among human plasma lipoproteinsS Urien, P Riant, E Albengres, et al.
Pharmacology|January 1, 1989
In vitro studies on the blood distribution of almitrineJ Barré, F Didey, S Urien, et al.
Biochemical and Biophysical Research Communications|July 24, 1998
Role of bilirubin in the regulation of the total peroxyl radical trapping antioxidant activity of plasma in sickle cell diseaseE Dailly, S Urien, J Barré, et al.
Journal of Cardiovascular Pharmacology|September 1, 1985
Plasma protein binding and erythrocyte partitioning of nicardipine in vitroS Urien, E Albengres, A Comte, et al.
Clinical Pharmacokinetics|January 1, 1994
Drug binding in plasma. A summary of recent trends in the study of drug and hormone bindingF Hervé, S Urien, E Albengres, et al.
Molecular Pharmacology|March 1, 1987
Binding of two anthranilic acid derivatives to human albumin, erythrocytes, and lipoproteins: evidence for glafenic acid high affinity bindingE Albengres, S Urien, P Riant, et al.
Biochemical Pharmacology|December 15, 1986
High plasma protein binding as a parameter in the selection of betablockers for lactating womenP Riant, S Urien, E Albengres, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Therapeutic Drug Monitoring|January 1, 1988
Comparison of different methods for lysing whole blood to measure cyclosporin A by radioimmunoassayC Hamberger, J Barre, S Urien, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
Location of probucol in lipoproteins inferred from compositional analysis of lipoprotein particles. An in-vitro studyJ M Bard, S Urien, J C Fruchart, et al.
Therapie|July 1, 1997
[Mediators involved in the nephrotoxicity of cyclosporin A]N Simon, J Barré, P Jolliet, et al.
Molecular Pharmacology|September 1, 1984
In vitro studies on the distribution of probucol among human plasma lipoproteinsS Urien, P Riant, E Albengres, et al.
Pharmacology|January 1, 1989
In vitro studies on the blood distribution of almitrineJ Barré, F Didey, S Urien, et al.
Biochemical and Biophysical Research Communications|July 24, 1998
Role of bilirubin in the regulation of the total peroxyl radical trapping antioxidant activity of plasma in sickle cell diseaseE Dailly, S Urien, J Barré, et al.
Journal of Cardiovascular Pharmacology|September 1, 1985
Plasma protein binding and erythrocyte partitioning of nicardipine in vitroS Urien, E Albengres, A Comte, et al.
Clinical Pharmacokinetics|January 1, 1994
Drug binding in plasma. A summary of recent trends in the study of drug and hormone bindingF Hervé, S Urien, E Albengres, et al.
Molecular Pharmacology|March 1, 1987
Binding of two anthranilic acid derivatives to human albumin, erythrocytes, and lipoproteins: evidence for glafenic acid high affinity bindingE Albengres, S Urien, P Riant, et al.
Biochemical Pharmacology|December 15, 1986
High plasma protein binding as a parameter in the selection of betablockers for lactating womenP Riant, S Urien, E Albengres, et al.
Pageof 13